Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions
    Published on 2023-09-15
    3 years ago
  • Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future
    Published on 2023-09-14
    3 years ago
  • Practical recommendations to improve retention of underrepresented minorities in science and medicine: an early career perspective
    Published on 2023-09-11
    3 years ago
  • Comment on: Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys
    Published on 2023-09-08
    3 years ago
  • Leucine-rich repeat kinase 2 limits dopamine D1 receptor signaling in striatum and biases against heavy persistent alcohol drinking
    Published on 2023-09-08
    3 years ago
  • G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression
    Published on 2023-09-06
    3 years ago
  • Reply to Bradford: Comment on increasing ecological validity in neuropsychopharmacology research on the relationship between alcohol use and uncertain stressors
    Published on 2023-09-06
    3 years ago
« Previous 1 … 102 103 104 105 106 … 143 Next »
Journal of Psychopharmacology
  • Oxytocin-induced facilitation of learning in a probabilistic task is associated with reduced feedback- and error-related negativity potentials
    Published on 2020-12-04
    5 years ago
  • Effects of lorazepam on prosaccades and saccadic adaptation
    Published on 2020-12-04
    5 years ago
  • AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar–Kyoto rats
    Published on 2020-11-17
    6 years ago
  • Pivotal mental states
    Published on 2020-11-11
    6 years ago
  • Muscimol-induced inactivation of the anterior cingulate cortex does not impair trace fear conditioning in the rat
    Published on 2020-11-09
    6 years ago
  • URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels
    Published on 2020-11-06
    6 years ago
  • Ketamine: A tale of two enantiomers
    Published on 2020-11-06
    6 years ago
« Previous 1 … 102 103 104 105 106 … 145 Next »
European Neuropsychopharmacology
  • Zopiclone to treat insomnia in older adults: A systematic review
    Published on 2021-05-21
    5 years ago
  • Bidirectional associations between treatment-resistant depression and general medical conditions
    Published on 2021-05-21
    5 years ago
  • MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans
    Published on 2021-05-20
    5 years ago
  • The myth that psychotherapy is more effective than pharmacotherapy in anxiety disorders
    Published on 2021-05-12
    5 years ago
  • White matter microstructure alterations in cortico-striatal networks are associated with parkinsonism in schizophrenia spectrum disorders
    Published on 2021-05-11
    5 years ago
  • Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling
    Published on 2021-05-08
    5 years ago
  • Cognitive reserve in mental disorders
    Published on 2021-05-07
    5 years ago
« Previous 1 … 102 103 104 105 106 … 166 Next »

   Pharma Pub